Ovarian cancer: can we reverse drug resistance?
Tan
David S P
DS
Section of Medicine, Institute of Cancer Research, Royal Marsden Hospital, Sutton, Surrey, UK.
Ang
Joo Ern
JE
Kaye
Stan B
SB
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019008:Drug Resistance, Neoplasm / Q000502:physiology*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents